Patterns of relapse in breast cancer: changes over time

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10549-009-0510-2PMID 19701704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials.

  2008cited by this paper
• Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.

  2008cited by this paper
• Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized controlled trials.

  2008cited by this paper
• Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up.

  2008cited by this paper
• Advances in adjuvant endocrine therapy for postmenopausal women.

  2008cited by this paper
• Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

  2007cited by this paper
• Competing Risks: A Practical Perspective

  2006cited by this paper
• American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.

  2006cited by this paper
• Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

  2006cited by this paper
• What's going on 乳癌 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group(EBCTCG). Lancet. 2005; 365: 1687-717. PMID: 15894097.--早期乳癌に対する化学療法・内分泌療法が乳癌再発・15年生存率に及

  2006cited by this paper
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• Optimizing adjuvant chemotherapy in early-stage breast cancer.

  2005cited by this paper
• Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients

  2004cited by this paper
• Statistical Inference

  2003cited by this paper
• Estrogen Receptors and Distinct Patterns of Breast Cancer Relapse

  2003cited by this paper
• Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.

  2003cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Clinical course and prognostic factors following bone recurrence from breast cancer.

  1998cited by this paper
• Bootstrap Methods and Their Application

  1998cited by this paper
• Adjuvant systemic therapy for breast cancer: a tale of relapse and survival.

  1994cited by this paper
• Bone‐Only Versus Visceral‐Only Metastatic Pattern in Breast Cancer: Analysis of 150 Patients A GOCS Study

  1990cited by this paper
• Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.

  1988cited by this paper
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

  1988cited by this paper
• Advanced breast cancer with bone-only metastases: a chemotherapeutically responsive pattern of metastases.

  1982cited by this paper

• Decline in the incidence of distant recurrence of breast cancer: A population-based health record linkage study, Australia 2001-2016.

  2023cites this paper
• Immunotherapy: an emerging modality to checkmate brain metastasis

  2023cites this paper
• Actual, Personalized Approaches to Preserve Cognitive Functions in Brain Metastases Breast Cancer Patients

  2022cites this paper
• Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases

  2022cites this paper
• Ecology and evolution of dormant metastasis.

  2022cites this paper
• Effect of molecular subtypes on radiotherapy response in patients with breast cancer brain metastasis

  2022cites this paper
• Brain metastases in de novo breast cancer: An updated population-level study from SEER database.

  2022cites this paper
• De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995

  2022cites this paper
• Live Cell Lineage Tracing of Dormant Cancer Cells

  2022cites this paper
• Clinicopathologic characteristics, metastasis-free survival, and skeletal-related events in 628 patients with skeletal metastases in a tertiary orthopedic and trauma center

  2021cites this paper
• Targeting brain metastases in breast cancer.

  2021cites this paper
• The Epidemiology of Bone Metastases in Malignant Diseases

  2021cites this paper
• A nomogram for predicting brain metastasis in patients with de novo stage IV breast cancer

  2021cites this paper
• Ventriculoperitoneal Shunt for CNS Metastasis in Breast Cancer: Clinical Outcomes Based on Intrinsic Subtype.

  2021cites this paper
• Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study

  2020cites this paper
• Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERβ2/5 pathway

  2020cites this paper
• Loco-regional recurrence trend and prognosis in young women with breast cancer according to molecular subtypes: analysis of 1099 cases

  2020cites this paper
• Metastatic breast cancer incidence, site and survival in Australia, 2001–2016: a population-based health record linkage study protocol

  2019cites this paper
• The impact of new systemic therapies on survival and time on hormonal treatment in hormone receptor–positive, human epidermal growth factor receptor 2–negative metastatic breast cancer: A population‐based study in British Columbia from 2003 to 2013

  2019cites this paper
• From latency to overt bone metastasis in breast cancer: potential for treatment and prevention

  2019cites this paper
• Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States

  2018cites this paper
• Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark

  2017cites this paper
• Contemporary Locoregional Recurrence Rates in Young Patients With Early-Stage Breast Cancer.

  2016cites this paper
• Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes

  2016cites this paper
• Pertuzumab, trastuzumab and docetaxel reduced the recurrence of brain metastasis from breast cancer: a case report

  2016cites this paper
• Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer.

  2016cites this paper
• The incidence of bone metastasis after early-stage breast cancer in Canada

  2016cites this paper
• Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis

  2015cites this paper
• Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis–Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer

  2015cites this paper
• Metastatic Breast Cancer: Biomolecular Characterization and Targeted Therapy

  2014cites this paper
• Huge decreases in the risk of breast cancer relapse over the last three decades

  2013cites this paper
• Mammographic Parenchymal Texture Analysis for Estrogen-Receptor Subtype Specific Breast Cancer Risk Estimation

  2012cites this paper
• The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival

  2012cites this paper
• Unfavourable pattern of metastases in M0 breast cancer patients during 1978-2008: a population-based analysis of the Munich Cancer Registry

  2011cites this paper